Clinical presentation and predictors of outcome in adult patients with community-acquired pneumonia

National Medical Journal of India

Volumn 10, Issue 4, 1997, Pages 169-172

  Dey, A B ^a   Nagarkar, K M ^a   Kumar, Vinod ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CEPHALOSPORIN DERIVATIVE;

ADULT; ARTICLE; CLINICAL FEATURE; HUMAN; OUTCOMES RESEARCH; PNEUMONIA; PREDICTION; PROGNOSIS; SURVIVAL RATE; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONIA, BACTERIAL; STATISTICS, NONPARAMETRIC;

EID: 0030820349     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Marrie TH, Durrant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5 years prospective study. Rev Infect Dis 1989;11:586-99.
2. Macfarlane JT, Finch RG, Ward MJ, Macrae AD. Hospital study of adult community-acquired pneumonia. Lancet 1982;2:255-8.
3. Woodhead MA, Macfarlane JT, Rodgers FG , Laverick A, Pilkington R, Macrae AD. Aetiology and outcome of severe community-acquired pneumonia. J Infect Dis 1985;10:204-10.
4. Venkatesan P, Gladman J, Macfarlane JT, Barer D, Berman P, Kinnear W, et al. A hospital study of community acquired pneumonia in the elderly. Thorax 1990;45: 254-8.
5. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalised for community acquired pneumonia. Ann Intern Med 1991;115:428-36.
6. The British Thoracic Society and the Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in 1982-83: A survey of aetiology, mortality, prognostic factors and outcome. Q J Med 1987;62:195-220.
7. Rello J, Quintana E, Ausina V, Net A, Prats O. A three-year study of severe community acquired pneumonia with emphasis on outcome. Chest 1993;103: 232-5.
8. Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P and the French Study Group for Community-Acquired Pneumonia in Intensive Care Unit. Severe community-acquired pneumonia: Etiology, epidemiology, and prognostic factors. Chest 1994; 105:1487-95.
9. Rogers RM, Weiler C, Rupenthal B. Impact of the respiratory intensive care unit on survival of patients with acute respiratory failure. Chest 1972;62:94-7.
10. Hook EW III, Horton CA, Schaberg DR. Failure of intensive care unit to influence mortality from pneumococcal bacteremia. JAMA 1983;249:1055-7.
11. Fayette H, Gray-Donald K. Dietary intake and biochemical indices of nutritional status in an elderly population, with estimates of the precision of the 7-d food record. Am J Clin Nutr 1991;54:478-88.
12. Ward W, Richardson A. Effect of age on liver protein synthesis and degradation. Hepatology 1991;14:935-48.
13. Niederman MS, Bass JB Jr, Campbell GD, Fein AM, Grossman RF, Mandell LA, et al. American Thoracic Society: Guidelines for the initial management of adults with community acquired pneumonia: Diagnosis, assessment of severity and initial antimicrobial therapy. Am Rev Respir Dis 1993;148:1418-26.
14. The British Thoracic Society. Guidelines for the management of community acquired pneumonia in adults admitted to hospital. Br J Hosp Med 1993;49:346-50.
15. Austrian R, Gold J. Pneumococcal bacterimia with especial reference to bacteraemic pneumococcal pneumonia. Ann Intern Med 1964;60:759-76.
16. Benson H, Akbarian M, Adler LN, Abelmann WH. Hemodynamic effects of pneumonia. I. Normal and hypodynamic responses. J Clin Invest 1970;49:791-8.